Dr. Anthony George Letai, MD
- Medicare services, 2024
- 129
- Medicare patients, 2024
- 36
- Publications
- 147
- Clinical trials
- 4
- MIPS score, 2024
- 84
- Practice address
- 75 Francis St, Boston, MA 02115
- Practice phone
- Call (617) 732-5500
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Brigham and Womens Hospital
Boston, Massachusetts
Find Dr. Letai's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Anthony George Letai is a hematologist and oncologist in Boston, Massachusetts
Dr. Letai practices at Brigham and Womens Hospital in Boston, Massachusetts.
Dr. Letai's NPI, 1851368435, was assigned on March 2, 2006. Dr. Letai holds Massachusetts license 153613.
- NPI
- 1851368435NPI Registry (opens in a new tab)
- NPI enumeration date
- March 2, 2006
- NPI status
- Active
- Practice phone
- (617) 732-5500
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Practice Data
Dr. Anthony George Letai practices at Brigham and Womens Hospital in Boston, Massachusetts
Dr. Letai's primary practice is Brigham and Womens Hospital, at 75 Francis St, Boston, MA 02115 in Suffolk County. The practice phone is (617) 732-5500.
- Brigham and Womens Hospital75 Francis St, Boston, MA 02115 · Suffolk CountyPhone(617) 732-5500
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Anthony George Letai is affiliated with 1 site of care
Dr. Letai's primary practice is Brigham and Womens Hospital in Boston, Massachusetts.
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Anthony George Letai's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Letai practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Brigham and Womens Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Anthony George Letai is one of 429 hematologists and oncologists in Massachusetts
Hematology and oncology is Dr. Letai's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Letai is licensed in Massachusetts.
Specialties and state licenses
- Hematology and oncology, MassachusettsPrimary
Hematologists and oncologists near Dr. Letai
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Anthony George Letai billed Medicare for 129 services in 2024
CMS data shows 129 Medicare services from Dr. Letai across 3 procedure codes in 2024, for 36 Medicare patients. Medicare paid $9,552 for them. Every service was in a facility, such as a hospital, rather than an office.
Dr. Letai's Medicare services by type, 2021 to 2024
- 2021
- 2024
- Office and hospital visits
- 2021: 602024: 129115%
Dr. Letai compared with the Massachusetts median for hematologists and oncologists, 2024
- Dr. Letai
- Massachusetts median
- Medicare services
- 129vs 49574% below
- Medicare patients
- 36vs 20082% below
Medians across 415 hematologists and oncologists in Massachusetts with Dmand AI profiles that report each measure.
Dr. Letai's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Letai?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Letai and other hematologists and oncologists in Massachusetts.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Anthony George Letai treated 36 Medicare patients in 2024, average age 74
CMS counts 36 Medicare patients who saw Dr. Letai in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Letai's median patient age at 72, with 100% women.
Dr. Letai's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Dr. Letai's Medicare patients by sex, 2024
- Women1644%
- Men2056%
Chronic conditions among Dr. Letai's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis58%
- Anxiety56%
- Chronic kidney disease56%
- Depression56%
- Mood disorders56%
- Ischemic heart disease36%
Share of Medicare patients with each condition. A patient can have several.
Dr. Letai's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women100%
- Men0%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Anthony George Letai scored 84 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Letai for performance year 2024, reported as part of a group.
Dr. Letai's MIPS scores, performance year 2024
- 84of 100Final score
- 65of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 69of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Source: Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Anthony George Letai has 147 publications on record
Dmand AI links 147 papers to Dr. Letai, published from 2010 to 2025. 2021 was the busiest year, with 13. The most frequent topics are Apoptosis, Cell Line, Tumor and Proto-Oncogene Proteins c-bcl-2. Dr. Letai has published most often in Blood Adv. Dr. Letai's most frequent co-authors are Matthew S. Davids, MD, Marina Y. Konopleva, MD, PhD and David M. Weinstock, MD.
Dr. Letai's papers by year, 2016 to 2025
Topics Dr. Letai writes about most
- Apoptosis
- Cell Line, Tumor
- Proto-Oncogene Proteins c-bcl-2
- Mitochondria
- Sulfonamides
- Antineoplastic Agents
- Drug Resistance, Neoplasm
- Myeloid Cell Leukemia Sequence 1 Protein
Dr. Letai's most frequent co-authors
- Matthew S. Davids, MD13 shared papers
- Marina Y. Konopleva, MD, PhD8 shared papers
- David M. Weinstock, MD6 shared papers
Recent publications by Dr. Letai
Cell Death Differ
Cell Death Differ
Nat Rev Cancer
See who Dr. Letai researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Letai works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Anthony George Letai has worked on 4 clinical trials
Dmand AI links Dr. Letai to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, B-Cell and Lymphoma, Mantle-Cell. BeiGene sponsors the most, 3. Open Payments lists research payments to Dr. Letai that name 7 trials.
Conditions in Dr. Letai's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
- Lymphoma, Mantle-Cell
- Multiple Myeloma
- Blood Protein Disorders
Investigators on the most trials with Dr. Letai
- Eric David Jacobsen, MD3 shared trials
- Stephanie Bernstein, MD2 shared trials
- Jacalyn M. Rosenblatt, MD2 shared trials
Recent clinical trials with Dr. Letai
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Anthony George Letai received $133,291 in industry payments from 2016 to 2024
CMS Open Payments shows 55 general payments to Dr. Letai from 12 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 90% of the total. AstraZeneca Pharmaceuticals LP paid the most, $78,980. It also lists 79 research payments totaling $491,750 from 2016 to 2025, naming 7 clinical trials.
General payments to Dr. Letai by program year, 2016 to 2024
General payments to Dr. Letai by kind, 2016 to 2024
- Consulting fees$120,56590%
- Travel and lodging$12,0979%
- Food and beverage$6290%
Companies that paid Dr. Letai the most, 2016 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Anthony George Letai's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Anthony George Letai
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Anthony George Letai's NPI number?
Dr. Anthony George Letai's NPI number is 1851368435. It was assigned on March 2, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Anthony George Letai?
Dr. Anthony George Letai is a hematologist and oncologist in Boston, Massachusetts. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Anthony George Letai practice?
Dr. Letai practices at 75 Francis St, Boston, MA 02115. Dr. Letai's primary practice is Brigham and Womens Hospital in Boston, Massachusetts.
What is Dr. Anthony George Letai's office phone number?
The practice phone on file for Dr. Letai is (617) 732-5500.
What is Dr. Anthony George Letai's medical license number?
Dr. Letai holds Massachusetts license 153613.
Does Dr. Anthony George Letai accept Medicare?
Yes. CMS data shows Dr. Letai billed Medicare for 129 services in 2024.
What is Dr. Anthony George Letai's MIPS score?
Dr. Letai's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.
How many Medicare patients does Dr. Anthony George Letai see?
CMS counts 36 Medicare patients who saw Dr. Letai in 2024, with an average age of 74.
What services does Dr. Anthony George Letai bill to Medicare?
In 2024, Dr. Letai's most billed Medicare services were hospital inpatient care (99232), hospital inpatient care (99222) and hospital inpatient care (99239).
Has Dr. Anthony George Letai received payments from drug or device companies?
CMS Open Payments shows $133,291 in general payments to Dr. Letai from 12 companies from 2016 to 2024. The largest total came from AstraZeneca Pharmaceuticals LP.
Show 3 more questionsShow fewer questions
How long has Dr. Anthony George Letai been practicing?
Dr. Letai graduated from medical school in 1995, 31 years ago.
Does Dr. Anthony George Letai do research?
Dmand AI links 147 publications to Dr. Letai, published from 2010 to 2025. Dr. Letai has worked on 4 clinical trials.
Who does Dr. Anthony George Letai publish with?
Dr. Letai's most frequent co-authors are Matthew S. Davids, MD (13 shared papers), Marina Y. Konopleva, MD, PhD (8 shared papers) and David M. Weinstock, MD (6 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in Massachusetts by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card